Grifols Clearwater Exposed: The Untold Story - Away State Journal
Grifols introduces HyperHEP B® (hepatitis B immune globulin [human]), a new formulation to treat patients exposed to hepatitis B
Grifols is a leading global healthcare company. Our trusted and innovative plasma-derived medicines, other biopharmaceuticals and solutions in transfusion medicine enable millions of patients around the world to lead more productive lives.
Grifols Plasma has united some of the best plasma donation centers in the industry under our Grifols network, allowing you to donate plasma across the nation.
Grifols is a leading global healthcare company that develops plasma-derived medicines and other innovative biopharmaceutical solutions that enable millions of patients around the world to lead more productive lives.
Grifols, S.A. (Catalan: [ˈɡɾifuls]) is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Catalonia, Spain, in 1909.
Grifols is a global healthcare company committed to improving people’s health and well-being. Our more than 23,800 employees in more than 30 countries and regions develop, produce, and market plasma-derived medicines as well as innovative biotech and diagnostic solutions in more than 110 countries.
Grifols is a global healthcare company that since 1909 has enhanced the health and well-being of people around the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries.
Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people around the world. The company develops, produces and provides innovative healthcare services and solutions in more than 110 countries.
